Extension of life span in normal human cells by telomerase activation: A revolution in cultural senescence

Journal of Anti-Aging Medicine

Volumn 1, Issue 2, 1998, Pages 125-130

  Vaziri, Homayoun ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000197194     PISSN: 10945458     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.1.1998.1.125     Document Type: Article

References (44)

1. Hayflick L, and Moorhead P: The serial cultivation of human diploid strains. Cell Res 1961;25:585-621.
2. Olovnikov AM: A theory of marginotomy. Doklay Biochem 1971;201:394-397.
3. Moyzis RK, Buckingham JM, Cram LS, et al.: A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988;85:6622-6626.
4. Harley CB, Futcher AB, and Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-460.
5. Hastie ND, Dempster M, Dunlop MG, et al.: Telomere reduction in human colorectal carcinoma and with ageing [see comments]. Nature 1990;346:866-868.
6. Vaziri H, Schachter F, Harley CB, et al.: Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Gene 1993;52:661-667.
7. Allsopp RC, Vaziri H, Patterson C, et al.: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992;89:10114-10118.
8. Harley CB: Telomere loss: Mitotic clock or genetic time bomb? Mutat Res 1991;256:271-282.
9. Lundblad V, and Szostak JW: A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 1989;57:633-643.
10. Shampay J, Szostak JW, and Blackburn EH: DNA sequences of telomeres maintained in yeast. Nature 1984;310:154-157.
11. Greider CW and Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985;43:405-413.
12. Morin GB: The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTA-GGG repeats. Cell 1989;59:521-529.
13. Counter CM, Avilion AA, LeFeuvre CE, et al.: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-1929.
14. Counter CM, Hirte HW, Bacchetti S, et al.: Telomerase activity in human ovarian carcinoma [see comments]. Proc Natl Acad Sci USA 1994;91:2900-2904.
15. Kim NW, Piatyszek MA, Prowse KR, et al.: Specific association of human telo-merase activity with immortal cells and cancer [see comments]. Science 1994;266:2011-2015.
16. Counter CM, Botelho FM, Want P, et al.: Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994;68:3410-3414.
17. Harley CB, Vaziri H, Counter CM, et al.: The telomere hypothesis of cellular aging. Exp Gerontol 1992;27: 375-382.
18. Lendvay TS, Morris DK, Sah J, et al.: Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. Genetics 1996;144:1399-1412.
19. Lingner J, Hughes TR, Shevchenko A, et al.: Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 1997;276:561-567.
20. Counter CM, Meyerson M, Eaton EN, et al.: The catalytic subunit of yeast telomerase. Proc Natl Acad Sci USA 1997;94:9202-9207.
21. Nakamura TM, Morin GB, Chapman KB, et al.: Telomerase catalytic subunit homologs from fission yeast and human. Science 1997;277:955-959.
22. Meyerson M, Counter CM, Ng Eaton E, et al.: hEST2, the putative human telo-merase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997;90:785-795.
23. Harrington L, Zhou W, McPhail T, et al.: Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev 1997; 11:3109-3115.
24. Kilian A, Bowtell DL, Abud HE, et al.: Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 1997;6:2011-2019.
25. Weinrich SL, Pruzan R, Ma L, et al.: Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 1997;17:498-502.
26. Collins K, Kobayashi R, and Greider CW: Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell 1995;81:677-686.
27. Feng J, Funk WD, Wang S, et al.: RNA component of human telomerase. Science 1995;269:1236.
28. Vaziri H, and Benchimol S: Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 1998;8:279-282.
29. Nakayama J, Tahara H, Tahara E, et al.: Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 1998;18:65-68.
30. Bodnar AG, Ovellette M, Frolkis M, et al.: Extension of life-span by introduction of telomerase into normal human cells. Science 1998;279:349-352.
31. Burghes AH, Logan C, Hu X, et al.: A cDNA clone from the Duchenne/Becker muscular dystrophy gene. Nature 1987;328:434-437.
32. Koenig M, Hoffman EP, Bertelson CJ, et al.: Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987;50:509-517.
33. Miller RG, Sharma KR, Pavlath GK, et al.: Myoblast implantation in Duchenne muscular dystrophy: The San Francisco study. Muscle Nerve 1997;20:469-478.
34. Blau HM, Webster C, and Pavlath GK: Defective myoblasts identified in Duchenne muscular dystrophy. Proc Natl Acad Sci USA 1983;80:4856-4860.
35. Webster C, and Blau HM: Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: implications for cell and gene therapy. Somat Cell Mol Genet 1990;16:557-565.
36. Decray S, Mouly V, Ben Hamida C, et al.: Replicative potential and telomere length in human skeletal muscle: Implications for satellite cell-mediated gene therapy. Hum Gene Ther 1997;8:1429-1438.
37. Oexle K, Zwirner A, Freudenberg K, et al.: Examination of telomere lengths in muscle tissue casts doubt on replicative aging as cause of progression in Duchenne muscular dystrophy. Pediat Res 1997;42: 226-231.
38. Vaziri H, Dragowska W, Allsopp RC, et al.: Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994;91:9857-9860.
39. + cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996;10:17-22.
40. Lunardi-Iskandar Y, Georgoulias V, Bertoli AM et al.: Impaired in-vitro proliferative hemopoietic precursors in HIV-1-infected subjects. Leuk Res 1989;13: 573-581.
41. Moore ASM: Hematopoietic reconstitution: New approaches. Clinical Cancer Research 1995;1:3-9.
42. Sandell LL, and Zakian VA: Loss of a yeast telomere: Arrest, recovery, and chromosome loss. Cell 1993;75: 729-739.
43. Vaziri H, and Benchimol S: From telomere loss to p53 induction and activation of a DNA-damage pathway at senescence: The telomere loss/DNA damage model of cell aging. Exp Gerontol 1996;31:295-301.
44. Vaziri H, West MD, Allsopp RC, et al.: ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the posttranslational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J 1997;16:6018-6033.